Skip to content

Released Aug 7, 2012

10-Q filed Aug 7, 2012, 38 days after period end · 0001104659-12-055214

Q2 2012 · 10-Q
Revenue$14.60M+29.7% vs Q2 2011+19.2% vs Q1 2012
Net income—
EPS Diluted-$0.38N/M vs Q2 2011N/M vs Q1 2012
Operating Income-$40,834,000N/M
Operating Cash Flowderived-$43,107,000N/M
Free Cash Flowderived-$45,502,000N/M
Margins · derived
Operating margin-279.6%−111.3 pt vs Q2 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2012Q2 2011Q2 2010
Revenue$14.60M$11.26M$9.19M
Net Income—-$18.84M-$17.14M
EPS Diluted-$0.38-$0.19-$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR